| James R Dilullo, | |
|
280 Jackson Rd, Atco, NJ 08004-1645 | |
| (856) 767-5757 | |
| Not Available |
| Full Name | James R Dilullo |
|---|---|
| Gender | Male |
| Speciality | Counselor - Mental Health |
| Location | 280 Jackson Rd, Atco, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699044313 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James R Dilullo, 280 Jackson Rd, Atco, NJ 08004-1645 Ph: (856) 767-5757 | James R Dilullo, 280 Jackson Rd, Atco, NJ 08004-1645 Ph: (856) 767-5757 |
News Archive
Selecting the right packaging to get precious cargo from point A to point B can be a daunting task at the post office. For some time, scientists have wrestled with a similar set of questions when packaging medicine for delivery in the bloodstream:
The link between obesity and the risk of endometrial cancer has been well documented. A new study, however, shows that an even lower body mass index (BMI) than previously thought can signal an increased risk in Asian women with postmenopausal bleeding. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).
Scientists at the University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have uncovered how the body's immune system launches its survival response to the notorious and deadly bacterium anthrax.
Actavis, Inc., a leading specialty pharmaceutical company, today announced that is has reached a settlement agreement with AstraZeneca resolving outstanding patent litigation related to Actavis' generic version of rosuvastatin calcium 5, 10, 20 and 40 mg tablets, the generic version of Crestor tablets, as well as Actavis' rosuvastatin zinc alternate salt product.
Bionovo, today announced the publication of a study demonstrating that ERb causes cancer cell growth arrest by inactivating critical genes and enzymes responsible for cell growth. These results provide evidence that drugs that stimulate the production of or activate ERb are potential new therapies to prevent breast cancer.
› Verified 3 days ago
Leahtrice Harris, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2135 Tremont Ave, Atco, NJ 08004 Phone: 856-767-4207 | |
Emily Catherine Eppolite, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2259 Camilla Ave, Atco, NJ 08004 Phone: 609-481-8784 | |
Mrs. Ramonita Hermes, CSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 280 Jackson Rd, Atco, NJ 08004 Phone: 856-767-5757 | |
Rasheeda Jones, Counselor Medicare: Not Enrolled in Medicare Practice Location: 226 Camden Avenue, Atco, NJ 08004 Phone: 856-379-8774 | |
Asia Davy, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1022 Martha Blvd, Atco, NJ 08004 Phone: 609-267-5928 | |
Tonette Clark, Counselor Medicare: Not Enrolled in Medicare Practice Location: 280 Jackson Rd, Atco, NJ 08004 Phone: 856-767-5757 | |
Ms. Rani Baten, Counselor Medicare: Not Enrolled in Medicare Practice Location: 280 Jackson Rd, Atco, NJ 08004 Phone: 856-262-8920 |